Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 704937, 11 pages
http://dx.doi.org/10.1155/2014/704937
Research Article

Differential Expression and Immunolocalization of Antioxidant Enzymes in Entamoeba histolytica Isolates during Metronidazole Stress

1School of Life Sciences, Jawaharlal Nehru University, New Delhi 110070, India
2School of Environmental Sciences, Jawaharlal Nehru University, New Delhi 110070, India

Received 27 February 2014; Revised 29 April 2014; Accepted 13 May 2014; Published 12 June 2014

Academic Editor: Miriam Rodriguez-Sosa

Copyright © 2014 Lakshmi Rani Iyer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M.-H. Choi, D. Sajed, L. Poole et al., “An unusual surface peroxiredoxin protects invasive Entamoeba histolytica from oxidant attack,” Molecular and Biochemical Parasitology, vol. 143, no. 1, pp. 80–89, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Sen, N. S. Chatterjee, M. A. Akbar, N. Nandi, and P. Das, “The 29-kilodalton thiol-dependent peroxidase of Entamoeba histolytica is a factor involved in pathogenesis and survival of the parasite during oxidative stress,” Eukaryotic Cell, vol. 6, no. 4, pp. 664–673, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Bruchhaus, S. Richter, and E. Tannich, “Removal of hydrogen peroxide by the 29 kDa protein of Entamoeba histolytica,” Biochemical Journal, vol. 326, no. 3, pp. 785–789, 1997. View at Google Scholar · View at Scopus
  4. H. W. Murray, S. B. Aley, and W. A. Scott, “Susceptibility of Entamoeba histolytica to oxygen intermediates,” Molecular and Biochemical Parasitology, vol. 3, no. 6, pp. 381–391, 1981. View at Google Scholar · View at Scopus
  5. E. Ghadirian, S. D. Somerfield, and P. A. L. Kongshavn, “Susceptibility of Entamoeba histolytica to oxidants,” Infection and Immunity, vol. 51, no. 1, pp. 263–267, 1986. View at Google Scholar · View at Scopus
  6. M. A. Akbar, N. S. Chatterjee, P. Sen et al., “Genes induced by a high-oxygen environment in Entamoeba histolytica,” Molecular and Biochemical Parasitology, vol. 133, no. 2, pp. 187–196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Isakov, R. Siman-Tov, C. Weber, N. Guillen, and S. Ankri, “Trichostatin A regulates peroxiredoxin expression and virulence of the parasite Entamoeba histolytica,” Molecular and Biochemical Parasitology, vol. 158, no. 1, pp. 82–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Hughes, C. W. Lee, C. F. Holm et al., “Identification of Entamoeba histolytica thiol-specific antioxidant as a GalNAc lectin-associated protein,” Molecular and Biochemical Parasitology, vol. 127, no. 2, pp. 113–120, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Ramos-Martínez, A. Olivos-García, E. Saavedra et al., “Entamoeba histolytica: oxygen resistance and virulence,” International Journal for Parasitology, vol. 39, no. 6, pp. 693–702, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. H. Davis, X. Zhang, J. Guo, R. R. Townsend, and S. L. Stanley Jr., “Comparative proteomic analysis of two Entamoeba histolytica strains with different virulence phenotypes identifies peroxiredoxin as an important component of amoebic virulence,” Molecular Microbiology, vol. 61, no. 6, pp. 1523–1532, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Martinez-Paolomo and M. Martinez-Baez, “Selective primary health care: strategies for control of disease in the developing world. X. Amebiasis,” Reviews of Infectious Diseases, vol. 5, no. 6, pp. 1093–1102, 1983. View at Publisher · View at Google Scholar
  12. D. Leitsch, D. Kolarich, I. B. H. Wilson, F. Altmann, and M. Duchêne, “Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase,” PLoS Biology, vol. 5, no. 8, article e211, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. K. M. Land and P. J. Johnson, “Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa,” Drug Resistance Updates, vol. 2, no. 5, pp. 289–294, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. N. A. Samarawickrema, D. M. Brown, J. A. Upcroft, N. Thammapalerd, and P. Upcroft, “Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica,” Journal of Antimicrobial Chemotherapy, vol. 40, no. 6, pp. 833–840, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Wassmann, A. Hellberg, E. Tannich, and I. Bruchhaus, “Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase,” Journal of Biological Chemistry, vol. 274, no. 37, pp. 26051–26056, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Tazreiter, D. Leitsch, E. Hatzenbichler et al., “Entamoeba histolytica: response of the parasite to metronidazole challenge on the levels of mRNA and protein expression,” Experimental Parasitology, vol. 120, no. 4, pp. 403–410, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Schlosser, D. Leitsch, and M. Duchěne, “Entamoeba histolytica: identification of thioredoxin-targeted proteins and analysis of serine acetyltransferase-1 as a prototype example,” Biochemical Journal, vol. 451, no. 2, pp. 277–288, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. C. G. Clark and L. S. Diamond, “Methods for cultivation of luminal parasitic protists of clinical importance,” Clinical Microbiology Reviews, vol. 15, no. 3, pp. 329–341, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. G. L. Robinson, “The laboratory diagnosis of human parasitic amoebae,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 62, pp. 285–294, 1968. View at Google Scholar
  20. S. Srivastava, S. Bhattacharya, and J. Paul, “Species- and strain-specific probes derived from repetitive DNA for distinguishing Entamoeba histolytica and Entamoeba dispar,” Experimental Parasitology, vol. 110, no. 3, pp. 303–308, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. B. E. Torian, B. M. Flores, V. L. Stroeher, F. S. Hagen, and W. E. Stamm, “cDNA sequence analysis of a 29-kDa cysteine-rich surface antigen of pathogenic Entamoeba histolytica,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 16, pp. 6358–6362, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Bruchhaus and E. Tannich, “Analysis of the genomic sequence encoding the 29-kDa cysteine-rich protein of Entamoeba histolytica,” Tropical Medicine and Parasitology, vol. 44, no. 2, pp. 116–118, 1993. View at Google Scholar · View at Scopus
  23. N. Sahoo, E. Labruyère, S. Bhattacharya, P. Sen, N. Guillén, and A. Bhattacharya, “Calcium binding protein 1 of the protozoan parasite Entamoeba histolytica interacts with actin and is involved in cytoskeleton dynamics,” Journal of Cell Science, vol. 117, no. 16, pp. 3625–3634, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. G. D. Jhingan, S. K. Panigrahi, A. Bhattacharya, and S. Bhattacharya, “The nucleolus in Entamoeba histolytica and Entamoeba invadens is located at the nuclear periphery,” Molecular and Biochemical Parasitology, vol. 167, no. 1, pp. 72–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. A. Upcroft and P. Upcroft, “Drug susceptibility testing of anaerobic protozoa,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 6, pp. 1810–1814, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Husain, G. Jeelani, D. Sato, and T. Nozaki, “Global analysis of gene expression in response to L-Cysteine deprivation in the anaerobic protozoan parasite Entamoeba histolytica,” BMC Genomics, vol. 12, article 275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. B. Vicente, G. M. Ehrenkaufer, L. M. Saraiva, M. Teixeira, and U. Singh, “Entamoeba histolytica modulates a complex repertoire of novel genes in response to oxidative and nitrosative stresses: implications for amebic pathogenesis,” Cellular Microbiology, vol. 11, no. 1, pp. 51–69, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Tachibana, S. Kobayashi, Y. Kato et al., “Identification of a pathogenic isolate specific 30,000 Mr antigen of Entamoeba histolytica by using a monoclonal antibody,” Infection and Immunity, vol. 58, no. 4, pp. 955–9960, 1990. View at Google Scholar · View at Scopus
  29. X.-J. Cheng, E. Yoshihara, T. Takeuchi, and H. Tachibana, “Molecular characterization of peroxiredoxin from Entamoeba moshkovskii and a comparison with Entamoeba histolytica,” Molecular and Biochemical Parasitology, vol. 138, no. 2, pp. 195–203, 2004. View at Publisher · View at Google Scholar · View at Scopus